Enhanced MRI Study for Epilepsy and Healthy Volunteers
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether a special MRI contrast agent (Ferumoxytol) can improve brain imaging in healthy people and people with temporal lobe epilepsy. It may help doctors see more detail in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are either a healthy volunteer OR have temporal lobe epilepsy with a specific MRI finding called hippocampal sclerosis.
- You can speak English.
- You are not pregnant or breastfeeding.
- You have no known allergy to Feraheme (an MRI contrast dye) or to any IV iron product.
- You weigh under 127.5 kg (about 281 pounds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special MRI can better locate the area in the brain where seizures start in people with drug-resistant focal epilepsy, particularly those with a specific type called MTLE. If successful, this could help guide surgery to stop seizures.
This study tests whether a special iron-based contrast agent called ferumoxytol can improve MRI images of arteries affected by atherosclerosis. It may help doctors see blockages or inflammation more clearly.
This trial tests whether two special MRI contrast medicines—gadolinium and ferumoxytol—can better diagnose problems in the brain or central nervous system. It may help doctors identify what’s causing symptoms or abnormal brain findings.
This trial uses a special iron-based contrast agent called ferumoxytol during an MRI scan to get clearer pictures of your veins. It's for people who may have vein blockages or other vein issues that need better imaging.
This study uses advanced MRI scans to look at brain structure in people with temporal lobe epilepsy. It may help doctors better understand the condition and improve treatment.
This early-phase study uses a special MRI approach to look for signs that the “blood-brain barrier” is breaking down in people with drug-resistant epilepsy. It may help researchers understand what is happening in the brain and guide future treatments, though it is primarily a testing/study study.
Hear when a new Epilepsy, Temporal Lobe trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.